Dr. Yacoub Haddad
Yacoub Haddad is a certified Pediatrician with a career both in the clinical and the pharmaceuticals sectors. Dr Haddad is currently the Director of Government Affairs for the MEAP region at Abbvie Biopharmaceuticals, and chairs PhRMAG, the Pharmaceutical Trade Association in the GCC. Between 1997 and 2013 Dr Haddad held many positions at MSD in the Middle East with increasing responsibilities both in the medical department and in management. Between 1982 and 1996 he practiced Pediatrics both in public and private hospitals in many countries in the Middle East region. Dr Haddad’s expertise is in Healthcare policies and Industrial policies in the Middle East. He is an invited speaker at many regional and international conferences on Healthcare financing, Intellectual Property, Counterfeit, and Pricing.
Director, ABPI/PMCPA UK
Heather chairs the Code of Practice Panel, which considers complaints submitted under the Code in the first instance, and is responsible for the overall running of the organisation. Heather also works with IFPMA and EFPIA in relation to their codes of practice. Heather has a degree in pharmacology and joined the ABPI in 1984. Heather has been working full time on the Code of Practice since 1989 and has been Director of the Authority since 1997.
Manager, Influenza Vaccines & Code Compliance, IFPMA
Tamara Music joined IFPMA in 2007 and is responsible for the organization’s work on Market Access policies, including health technology assessment (HTA) and international health systems. Tamara also leads IFPMA’s ethics and compliance initiatives which include the global implementation and management of the IFPMA Code of Practice and the Code Compliance Network (CCN). In her capacity, Tamara closely works with international institutions, governments and non-governmental organizations in building consensus and partnerships that support public health policies and benefit patients worldwide.
Tamara received her B.A. in Political Science from University of California, Berkeley, her Masters in International Affairs from the Graduate Institute in Geneva, and Certificate of Advanced Studies (CAS) in Pharmaceutical Economics and Policy from University of Lausanne, School of Business (HEC).
5th May 2014